🇺🇸 Alpha-lipoic acid in United States

3,466 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 3,466

Most-reported reactions

1. Fatigue — 607 reports (17.51%)
2. Nausea — 412 reports (11.89%)
3. Diarrhoea — 373 reports (10.76%)
4. Pain — 362 reports (10.44%)
5. Headache — 345 reports (9.95%)
6. Dizziness — 316 reports (9.12%)
7. Drug Ineffective — 313 reports (9.03%)
8. Neuropathy Peripheral — 254 reports (7.33%)
9. Dyspnoea — 246 reports (7.1%)
10. Arthralgia — 238 reports (6.87%)

Source database →

Frequently asked questions

Is Alpha-lipoic acid approved in United States?

Alpha-lipoic acid does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Alpha-lipoic acid in United States?

Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara is the originator. The local marketing authorisation holder may differ — check the official source linked above.